Acta Paediatrica · 1994 · 19 citations · 16 references
Life SciencesInfectious DiseasesPediatricsAntimicrobial ResistanceMedical MicrobiologyPediatric Infectious DiseasesAntibiotic ResistanceBacterial EpidemiologyBacterial InfectionsInfant Infectious DiseasesPediatric Antibiotic TherapyPediatric Antimicrobial TherapyAntibiotic Susceptibility Data AnalysisAntibiotic Susceptibility TestingAntimicrobial Resistance In ChildrenBacterial Infections In NewbornsBacterial Meningitis TreatmentEpidemiology Of Bacterial InfectionsMeningitis Antibiotic TherapyStreptococcus Species
From January 1988 to November 1992, 107 (3.5%) of 3074 postneonatal children admitted to the Children's Emergency Room, University of Maiduguri Teaching Hospital, Nigeria, had sporadic pyogenic meningitis; 66 (61.7%) were aged < or = 12 months. Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae together were responsible for 77.3% (58) of 75 culture-proven cases, 13.4% (10) had Enterobacteriaceae, 5.3% (4) had Staphylococcus aureus and 4% (3) untyped alpha-haemolytic streptococci. Fifty percent of 62 bacteria were resistant to ampicillin, 47.2% of 36 to penicillin and 10.7% of 56 to chloramphenicol; none of 21 bacteria was simultaneously resistant to all three antibiotics. Up until 1992, we have encountered treatment failure with a regimen containing chloramphenicol in only 2 of 53 patients; the 2 patients had coliform meningitis. Non-meningococcal bacteria are an important cause of sporadic pyogenic meningitis in sub-Saharan Nigeria and chloramphenicol is the most appropriate initial drug of choice at the present time for the management of sporadic meningitis.
16
MENINGOCOCCAL DISEASE AND SEASON IN SUB-SAHARAN AFRICA
Brian Greenwood, A. K. Bradley, I.S. Blakebrough et al. · The Lancet · 1984 · 148 citations
George H. McCracken, John D. Nelson, Sheldon L. Kaplan et al. · The Pediatric Infectious Disease Journal · 1987 · 76 citations